A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis

Psoriasis and Beyond: A Worldwide Survey on the Understanding of Psoriatic Disease Among Patients With Psoriasis and Psoriatic Arthritis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04614831

Enrollment

4978

Registered

2020-11-04

Start date

2020-11-12

Completion date

2021-06-03

Last updated

2021-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plaque Psoriasis, Psoriatic Arthritis

Brief summary

The study is a Worldwide Survey on the Understanding of Psoriatic Disease among Patients with Psoriasis and Psoriatic Arthritis.

Detailed description

This is a cross-sectional, quantitative online survey of patients with psoriasis with or without concomitant psoriatic arthritis. Following assessment of participant eligibility via a 5-minute online screener, the 25-minute internet-based survey will be conducted without any follow-up.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

1. Patients who self-report to have been diagnosed with Psoriasis or Psoriasis and Psoriatic Arthritis before or at the time of data collection 2. Patients 18 years of age or older at the time of data collection 3. Patients who did not participate in surveys regarding Psoriasis or Psoriatic Arthritis in the last 4 weeks 4. Body Surface Area (BSA) of \>5 to \<10, with psoriasis affecting sensitive and/or prominent body parts: face, palms, hands, fingers, genitals, soles of feet or nails or a BSA of 10 and above, when psoriasis was at its worst

Design outcomes

Primary

Measure	Time frame	Description
A web-based survey will be answered by the participants. Data collected for the analysis of the primary objective include validated patient-reported outcomes (such as DLQI), as well as responses to non-validated questions.	1 Day of survey	To assess patients' understanding of psoriasis and psoriatic arthritis as part of a systemic disease and the humanistic and physical burden of living with the condition.

Secondary

Measure	Time frame	Description
A web-based survey will be answered by the participants. The data collected for the analysis of the secondary objectives include validated tools (such as PAM-13), as well as responses to non-validated questions.	1 Day of Survey	To assess the patient's perceptions and attitudes related to the relationship with their physician, the patient journey through the healthcare system, as well as barriers to self-management, diagnosis, patient perceptions on biologics, treatment expectations, and satisfaction with care.

Countries

Switzerland

Outcome results